Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 63.80M | € 83.32M | € 52.77M | € 99.29M | € 68.82M |
Total Assets | € 920.33M | € 781.36M | € 815.86M | € 764.63M | € 809.60M |
Total Debt | € 218.55M | € 125.88M | € 123.22M | € 186.89M | € 225.07M |
Net Debt | € 154.75M | € 42.56M | € 70.45M | € 87.60M | € 156.25M |
Total Liabilities | € 534.34M | € 391.39M | € 454.80M | € 423.08M | € 489.26M |
Stockholders Equity | € 385.97M | € 389.95M | € 361.04M | € 341.53M | € 320.32M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |